SculpTherapy- Dr. Edwin Ishoo at Boston Cosmetic Surgery Center Introduces an Innovative, Non-surgical Procedure for Dramatic Facial Rejuvenation- No Downtime.
(1888PressRelease) Increasing demand for non-surgical cosmetic options has led Dr. Edwin Ishoo to develop a revolutionary new combination procedure using Ultherapy®, Sculptra® and Fraxel® to achieve a truly effective non-surgical alternative to facelift - now available in the South Shore and Boston, Massachusetts exclusively at the Boston Cosmetic Surgery Center. Boston, MA-NH (1888PressRelease) Dr. Edwin Ishoo, the director of Boston Cosmetic Surgery Center, explains that "There are 3 main causes of facial aging. These include: 1. loss of deep facial structural support with fat and bone volume loss, leading to deflation and collapse of the face; 2.Collagen degradation as well as slow down of collagen synthesis leading to skin laxity and facial drooping; 3.Loss of skin elasticity due to sun exposure, smoking, chemicals and hormonal fluctuations causing skin texture and pigmentation irregularity." Dr. Ishoo adds, "Loss of deep facial fat starts the aging process around age 35 and continues, leading to facial collapse and sagging. in addition, the supporting substance of our skin, collagen is damaged as we age, causing the skin to appear wrinkled, pigmented and sagging." Dr. Ishoo reports that "SCULPTherapy is designed to achieve a natural looking facelift by maximally stimulating the body's own regenerative response." Dr. Ishoo has developed a specific regimen in which the patient is started on Sculptra® injection series of 3-4 treatments, each 4-6 weeks apart. Dr. Ishoo uses Sculptra® injections to create multi-layer volume replacement, which restores youthful three dimensional facial projection leading to a fuller and brighter appearance. Patients are then brought back in the middle of the Sculptra® series for a full face Ultherapy® treatment to tighten and tone loose or sagging skin creating more youthful facial definition. Such a combination approach is believed to hyper-stimulate collagen production and volume enhancement in the treatment areas beyond what either modality can achieve alone. Finally, 2 weeks after the last Sculptra® treatment, facial skin resurfacing is performed with Fraxel® to stimulate new surface collagen and remove the damaged top layer, causing the skin to become luminous, smooth and supple. The FDA-approved Ultherapy® System is considered a first-of-its-kind technology because unlike traditional lasers and RF devices of the past, Ultherapy® is able to